This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BIOLASE is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers. We have also accelerated our in-house production of certain key components that will significantly improve our gross margin in the future.
BIOLASE announced an arrangement with Pet Dental Services (PDS), the #1 non-anesthetic pet dental provider in the country, to integrate BIOLASE’s diode laser technology. According to the American Veterinary Dental Society, 80% of dogs and 70% of cats show signs of periodontal disease by the age of 3. .
OTCQX: SONX) (“Sonendo” or “company”), a leading dentaltechnology company and developer of the GentleWave® System, today announced that the company has entered into an Asset Purchase Agreement (“APA”) with Biolase, Inc. Biolase’s products advance the practice of dentistry and medicine for patients and healthcare professionals.
NASDAQ: BIOL) (the “company”), a global leader in dental lasers, recently announced that the company and its direct domestic subsidiaries have voluntarily initiated Chapter 11 proceedings (the “Bankruptcy Petitions”) in the United States Bankruptcy Court for the District of Delaware (the “Court”).
NASDAQ:BIOL) (the "Company"), a global leader in dental lasers, today announced that the Company and its direct domestic subsidiaries have voluntarily initiated Chapter 11 proceedings (the "Bankruptcy Petitions") in the United States Bankruptcy Court for the District of Delaware (the "Court"). Sonendo is a leading dentaltechnology company.
We organize all of the trending information in your field so you don't have to. Join 13,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content